ArticlePathobiology : journal of immunopathology, molecular and cellular biology2024

ATF4 as a Prognostic Marker and Modulator of Glutamine Metabolism in Oestrogen Receptor-Positive Breast Cancer.

Roshni Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.